From: Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa
Total Inc. impact (2018)
Total Incrementalcost (USD)
Incremental costper pt (USD) Yr 1
1wk AmBd/5FC
 vs 1wk AmBd/Flu (LC)
9,600,890
1373
 vs 2wk AmBd/Flu (SC)
2,045,359
293